A predictive computational framework for direct reprogramming between human cell types

Nature Genetics
Owen J L RackhamJulian Gough

Abstract

Transdifferentiation, the process of converting from one cell type to another without going through a pluripotent state, has great promise for regenerative medicine. The identification of key transcription factors for reprogramming is currently limited by the cost of exhaustive experimental testing of plausible sets of factors, an approach that is inefficient and unscalable. Here we present a predictive system (Mogrify) that combines gene expression data with regulatory network information to predict the reprogramming factors necessary to induce cell conversion. We have applied Mogrify to 173 human cell types and 134 tissues, defining an atlas of cellular reprogramming. Mogrify correctly predicts the transcription factors used in known transdifferentiations. Furthermore, we validated two new transdifferentiations predicted by Mogrify. We provide a practical and efficient mechanism for systematically implementing novel cell conversions, facilitating the generalization of reprogramming of human cells. Predictions are made available to help rapidly further the field of cell conversion.

References

May 28, 2004·Cell·Huafeng XieThomas Graf
Jun 23, 2006·Biological Reviews of the Cambridge Philosophical Society·Matthew K Vickaryous, Brian K Hall
Nov 22, 2007·Science·Junying YuJames A Thomson
Dec 13, 2007·Nucleic Acids Research·Derek WilsonSarah A Teichmann
Oct 14, 2008·Nature Biotechnology·Danwei HuangfuDouglas A Melton
Mar 11, 2009·Nature Reviews. Genetics·Juan M VaquerizasNicholas M Luscombe
Mar 17, 2009·Genome Biology·Debra L FultonRob Sladek
Apr 21, 2009·Nature Genetics·UNKNOWN FANTOM ConsortiumYoshihide Hayashizaki
Jan 29, 2010·Nature·Thomas VierbuchenMarius Wernig
Oct 29, 2010·Genome Biology·Simon Anders, Wolfgang Huber
May 31, 2011·BMC Systems Biology·Sudin BhattacharyaMelvin E Andersen
Jun 8, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ulrich PfistererMalin Parmar
Jul 4, 2012·Frontiers in Physiology·Max FlöttmannEdda Klipp
Dec 4, 2012·Nucleic Acids Research·Andrea FranceschiniLars J Jensen
Dec 25, 2012·Cell·Jose M PoloKonrad Hochedlinger
Apr 18, 2013·Journal of Molecular and Cellular Cardiology·Russell C AddisJohn D Gearhart
Apr 23, 2013·Nature Methods·Merja HeinäniemiIlya Shmulevich
Dec 10, 2013·Stem Cell Reports·Ji-Dong FuDeepak Srivastava
Jan 5, 2014·The Journal of Biological Chemistry·Qingjian ZouLiangxue Lai
Mar 29, 2014·Nature·Alistair R R ForrestYoshihide Hayashizaki
Aug 15, 2014·PLoS Computational Biology·Alex H LangPankaj Mehta
Aug 16, 2014·Cell·Patrick CahanJames J Collins
Jun 23, 2015·Nature Biotechnology·Ori Bar-NurKonrad Hochedlinger
Nov 26, 2015·Stem Cell Reports·Ana C D'AlessioRichard A Young

❮ Previous
Next ❯

Citations

Nov 5, 2016·Proceedings of the National Academy of Sciences of the United States of America·Drew G MichaelMichael R Brent
Oct 30, 2016·Cell Cycle·Uma S KamarajOwen J L Rackham
Apr 28, 2017·Nature Protocols·Arthur H RadleyPatrick Cahan
Apr 27, 2016·Current Opinion in Biotechnology·Deborah ChasmanSushmita Roy
Feb 2, 2017·Cell Biology and Toxicology·Britta J H DriessenLucienne A Vonk
Apr 21, 2017·Nucleic Acids Research·Andrew P HutchinsDuanqing Pei
Jun 25, 2017·Current Opinion in Genetics & Development·Jaber Firas, Jose M Polo
Mar 30, 2018·Nature Cell Biology·Mo Li, Juan Carlos Izpisua Belmonte
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Scott RonquistIndika Rajapakse
Feb 17, 2018·Genome Research·Joseph G AzofeifaRobin D Dowell
Oct 29, 2018·Development, Growth & Differentiation·Guizhong CuiNaihe Jing
Jun 17, 2016·Nature·Michael Eisenstein
Nov 30, 2018·The EMBO Journal·Sara-Jane DunnGraziano Martello
Sep 4, 2019·Nature Genetics·Shigeki HirabayashiYasuhiro Murakawa
Nov 19, 2019·Biotechnology and Bioengineering·Mee-Hae Kim, Masahiro Kino-Oka
Sep 13, 2016·Diabetes, Obesity & Metabolism·W StaelsH Heimberg
Jan 15, 2020·Cold Spring Harbor Perspectives in Biology·Iwo Kucinski, Berthold Gottgens
Oct 13, 2016·Annual Review of Genetics·Alan S L WongTimothy K Lu
Jun 1, 2017·Cell and Tissue Research·Michael M KaminskiSoeren S Lienkamp
Sep 7, 2017·Scientific Reports·Bijan AkbariAbdulshakour Mohammadnia
May 31, 2018·Molecular Medicine Reports·Guillermo-Issac Guerrero-RamirezVictor Trevino
Sep 8, 2018·Scientific Reports·András HartmannAntonio Del Sol
Jul 9, 2020·APL Bioengineering·Aditya Kumar, Prashant Mali
Jul 1, 2016·Proteomics·Patrick S StumpfBen D MacArthur
Nov 16, 2018·JCI Insight·Pietro E CippàAndrew P McMahon
Aug 8, 2018·NPJ Systems Biology and Applications·Pierre-Etienne CholleyMarco Antonio Mendoza-Parra
Feb 2, 2019·BMC Genomics·Alexander KanitzMihaela Zavolan
Mar 16, 2019·Frontiers in Neuroscience·Wenliang LeiGong Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.